BridgeBio Pharma’s heart disease drug meets main goal in late-stage study
The company said no safety concerns were identified in patients, adding that it intends t submit marketing applications to the US…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
BridgeBio Pharma
Sentynl Therapeutics and BridgeBio Pharma announce asset purchase agreement for Nulibry
Under the terms of the agreement, Sentynl will acquire global rights to Nulibry, and will be responsible for its ongoing…